For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...

Ulcerative colitis (UC) is a lifelong condition. That means you may try a lot of different treatments — and know how frustrating it can be when they don’t help. The nature of UC is “flare and ...

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

Oral small-molecule therapies are redefining first-line treatment in moderate to severe ulcerative colitis (UC) by offering noninfusion alternatives with rapid onset and high efficacy. Etrasimod, a ...

Credit: Getty Images What have we learned in recent years about the safety and efficacy of different biologics for the treatment of ulcerative colitis? Ulcerative colitis (UC) is a condition with a ...

Etrasimod, an investigational selective sphingosine 1-phosphate (S1P) receptor modulator, led to clinically meaningful improvements in patients with moderately to severely active ulcerative colitis ...

In patients with ulcerative colitis, initiation of biologic therapy within 12 months of diagnosis is linked to a lower risk ...

Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics, family communication, and side effects.

INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh™ (mirikizumab-mrkz) infusion (300 ...

There’s no way to cure ulcerative colitis (UC). But there are now lots of ways to treat UC. The first goal of treatment is to get your UC into remission. When your UC is in remission, it means the ...